Vladislav N. Evseev
Medical oncologist, Head of Chemotherapy Department
Vladislav N. Evseev
Medical Oncologist
Head of Chemotherapy Department
Education
| Institution | Specialization |
|---|---|
| Pavlov First Saint Petersburg State Medical University (2019) | General Medicine |
| Saint Petersburg State University | Residency in Oncology |
| Higher School of Oncology (Ne Naprasno Foundation grant) | Advanced Oncology Training |
| Saint Petersburg State University (2023) | Healthcare Management and Public Health |
| Moscow School of Management Skolkovo | MBA |
Professional Career
| Institution | Position |
|---|---|
| St. Luke's Clinical Hospital, Saint Petersburg | Oncologist, systemic treatment of solid tumors |
| BostonGene | Clinical analyst, precision oncology |
| Medsi, Saint Petersburg (from 2022) | Head of Oncology Department |
| Evgeny Ledin's Clinic (2025–present) | Head of Chemotherapy Department |
Specialties
Immunotherapy
Targeted Therapy
Hormone Therapy
Chemotherapy
Neoadjuvant Treatment
Molecular Genetic Diagnostics
Personalized Medicine
Achievements and Recognition
ESMO Exam in Medical Oncology
Top 7% worldwide, 1st result in Russia (2021)
Top 7% worldwide, 1st result in Russia (2021)
Forbes Russia «30 Under 30»
Long list nominee (2023)
Long list nominee (2023)
«Patients' Choice» Award
NaPopravku, 2022–2024
NaPopravku, 2022–2024
«New Names in Medicine» Award
Sobaka.ru, 2023
Sobaka.ru, 2023
Professional Society Membership
ESMO — European Society for Medical Oncology
ASCO — American Society of Clinical Oncology
RUSSCO — Russian Society of Clinical Oncology
Teaching and Public Activities
- Lecturer at the International Higher School of Medicine (Kazakhstan)
- Mentor at the Higher School of Oncology
- Chair of the Medical Advisory Board, Ne Naprasno Foundation
- Co-author: «Molecular Genetic Testing in Oncology» (RUSSCO, patient education series)
Patient Approach
Vladislav represents a new generation of oncologists, combining clinical experience with a deep understanding of tumor molecular biology. His approach is based on precision oncology: each treatment regimen is designed according to the molecular genetic profile of the tumor, enabling the most effective therapy for each individual patient.
Book a Consultation
Tell us about your situation — we will help determine the next steps
Or contact us directly: